Cite Filings / XENE / 0001564590-22-028780
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Xenon Pharmaceuticals Inc. · Filed 2022-08-09 · Acc 0001564590-22-028780

Documents 1

  • 10-Q Quarterly Report , xene-10q_20220630.htm

Around this filing

  • 2022-11-08 10-Q Quarterly Report
  • 2022-08-16 4 EVP, Drug Discovery sold 57,743 shares at an average $38.31 ($2,211,978)
  • 2022-08-16 4 Director sold 177,135 shares at an average $38.25 ($6,775,149)
  • 2022-08-09 10-Q Quarterly Report
  • 2022-08-09 8-K Results of operations
  • 2022-05-10 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading xene-10q_20220630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…